Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020]
Tumor type associations:
- Bladder
- Breast
- Cervical
- Colorectal
- Endometrial
- Esophageal
- Gastric
- Kidney
- Liver
- Lymphoma
- Melanoma
- Ovarian
- Pancreatic
- Prostate
- Enables protease binding
- DNA binding
- Enables single-stranded DNA binding
- NOT enables histone acetyltransferase activity
- Enables protein binding
- Part of nuclear ubiquitin ligase complex
- Located in chromosome, telomeric region
- Located in lateral element
- Located in nucleus
- Located in nucleoplasm
- Involved in telomere maintenance via recombination
- Involved in double-strand break repair via homologous recombination
- Involved in oocyte maturation
- Involved in inner cell mass cell proliferation
- DNA repair
- Fanconi anemia, complementation group D1
- Wilms tumor
- Breast cancer, male, susceptibility to
- Breast-ovarian cancer, familial, 2
- Glioblastoma 3
- Medulloblastoma
- Pancreatic cancer 2
- Prostate cancer
BRCA2 localizations – Subcellular Localization Database
ProteinBoxBot. PBB Protein BRCA.